Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Preisack

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|June 24, 2005
[Simplified production of multimedia based radiological learning objects using the flash format]P Jedrusik, M Preisack, F Dammann
The American Journal of Cardiology|August 1, 1989
Acute hemodynamic effects of adibendan, a new phosphodiesterase inhibitor, for severe congestive heart failureW Voelker, M Mauser, M Preisack, et al.
Seminars in Thrombosis and Hemostasis|January 1, 1993
First clinical experience with low molecular weight heparin LU 47311 (reviparin) for prevention of restenosis after percutaneous transluminal coronary angioplastyK M Schmid, M Preisack, W Voelker, et al.
Studies in Health Technology and Informatics|September 8, 2000
CardioOp: an integrated approach to teleteaching in cardiac surgeryR Friedl, M Preisack, M Schefer, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|June 24, 2005
[Simplified production of multimedia based radiological learning objects using the flash format]P Jedrusik, M Preisack, F Dammann
The American Journal of Cardiology|August 1, 1989
Acute hemodynamic effects of adibendan, a new phosphodiesterase inhibitor, for severe congestive heart failureW Voelker, M Mauser, M Preisack, et al.
Seminars in Thrombosis and Hemostasis|January 1, 1993
First clinical experience with low molecular weight heparin LU 47311 (reviparin) for prevention of restenosis after percutaneous transluminal coronary angioplastyK M Schmid, M Preisack, W Voelker, et al.
Studies in Health Technology and Informatics|September 8, 2000
CardioOp: an integrated approach to teleteaching in cardiac surgeryR Friedl, M Preisack, M Schefer, et al.
Pageof 1